Stonehage Fleming Financial Services Holdings Ltd Has $98.04 Million Stock Holdings in Zoetis Inc. $ZTS

Key Points

• Stonehage Fleming Financial Services Holdings Ltd reduced its stake in Zoetis Inc. by 3.1% during the 2nd quarter, bringing its holdings to 628,677 shares worth approximately $98.04 million.
• Zoetis reported earnings of $1.76 per share for the last quarter, exceeding analysts' expectations, with revenue of $2.46 billion and a year-over-year growth of 4.2%.
• The company announced a quarterly dividend of $0.50 per share, resulting in an annualized dividend yield of 1.4%, with an ex-dividend date on October 31st.

Stonehage Fleming Financial Services Holdings Ltd lessened its position in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 3.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 628,677 shares of the company's stock after selling 19,936 shares during the quarter. Zoetis comprises about 2.8% of Stonehage Fleming Financial Services Holdings Ltd's investment portfolio, making the stock its 16th largest position. Stonehage Fleming Financial Services Holdings Ltd owned approximately 0.14% of Zoetis worth $98,042,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in ZTS. Brighton Jones LLC increased its stake in shares of Zoetis by 180.4% in the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company's stock valued at $754,000 after acquiring an additional 2,978 shares during the last quarter. Farther Finance Advisors LLC raised its position in shares of Zoetis by 11.1% in the 1st quarter. Farther Finance Advisors LLC now owns 4,738 shares of the company's stock valued at $767,000 after acquiring an additional 474 shares during the period. SG Americas Securities LLC raised its position in shares of Zoetis by 61.8% in the 1st quarter. SG Americas Securities LLC now owns 20,782 shares of the company's stock valued at $3,422,000 after acquiring an additional 7,940 shares during the period. Rockland Trust Co. raised its position in shares of Zoetis by 1.3% in the 1st quarter. Rockland Trust Co. now owns 6,379 shares of the company's stock valued at $1,050,000 after acquiring an additional 83 shares during the period. Finally, NorthCrest Asset Manangement LLC raised its position in shares of Zoetis by 5.8% in the 1st quarter. NorthCrest Asset Manangement LLC now owns 26,389 shares of the company's stock valued at $4,345,000 after acquiring an additional 1,443 shares during the period. Institutional investors and hedge funds own 92.80% of the company's stock.

Zoetis Stock Down 1.6%

NYSE:ZTS opened at $141.05 on Friday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. The company has a market cap of $62.51 billion, a PE ratio of 24.28, a PEG ratio of 2.26 and a beta of 0.90. Zoetis Inc. has a 52-week low of $139.34 and a 52-week high of $196.55. The stock has a 50-day simple moving average of $149.24 and a 200 day simple moving average of $154.41.

Zoetis (NYSE:ZTS - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.14. The business had revenue of $2.46 billion during the quarter, compared to the consensus estimate of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.Zoetis's quarterly revenue was up 4.2% on a year-over-year basis. During the same period last year, the company earned $1.56 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, sell-side analysts expect that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, October 31st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. Zoetis's dividend payout ratio (DPR) is presently 34.42%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ZTS. Leerink Partners downgraded shares of Zoetis from an "outperform" rating to a "market perform" rating and cut their price target for the company from $180.00 to $155.00 in a research report on Thursday, July 17th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Zoetis in a research report on Wednesday. Stifel Nicolaus downgraded Zoetis from a "buy" rating to a "hold" rating and lowered their price target for the stock from $165.00 to $160.00 in a report on Wednesday, June 18th. Leerink Partnrs downgraded Zoetis from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 17th. Finally, Argus restated a "buy" rating and issued a $190.00 price target on shares of Zoetis in a report on Tuesday, September 9th. Four analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $196.71.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.